ERSTE Stock Biotec D02 VTIA
AT0000A1YFG4
ERSTE Stock Biotec D02 VTIA/ AT0000A1YFG4 /
NAV08/11/2024 |
Chg.+20.0999 |
Type of yield |
Investment Focus |
Investment company |
3,311.9299CZK |
+0.61% |
Full reinvestment |
Equity
Sector Biotechnology
|
Erste AM ▶ |
Investment goal
The ESPA STOCK BIOTEC fund invests in the most important biotech companies, primarily those in the USA. Equities from the Pacific region and Europe play a minor role, but are also selectively added to the fund. The currencies are not hedged against the euro. The fund is particularly suitable as an addition to an existing equity portfolio and is geared towards achieving long-term capital appreciation.
Master data
Type of yield: |
Full reinvestment |
Funds Category: |
Equity |
Country: |
United States of America |
Branch: |
Sector Biotechnology |
Benchmark: |
Solactive United States Biotechnology Index NTR |
Business year start: |
15/03 |
Last Distribution: |
- |
Depository bank: |
Erste Group Bank AG |
Fund domicile: |
Austria |
Distribution permission: |
Austria, Germany, Czech Republic |
Fund manager: |
Harald Kober, Tamas Menyhart |
Fund volume: |
235.91 mill.
EUR
|
Launch date: |
22/12/2017 |
Investment focus: |
- |
Conditions
Issue surcharge: |
4.00% |
Max. Administration Fee: |
0.63% |
Minimum investment: |
0.00 CZK |
Deposit fees: |
- |
Redemption charge: |
0.00% |
Key Investor Information: |
Download (Print version) |
Investment company
Funds company: |
Erste AM |
Address: |
Am Belvedere 1, 1100, Wien |
Country: |
Austria |
Internet: |
www.erste-am.at
|
Countries
United States of America |
|
78.89% |
United Kingdom |
|
9.10% |
Netherlands |
|
3.92% |
China |
|
1.96% |
Denmark |
|
1.19% |
Virgin Islands (British) |
|
1.06% |
Bermuda |
|
1.00% |
Canada |
|
0.85% |
Ireland |
|
0.69% |
Cash |
|
0.45% |
Singapore |
|
0.34% |
Cayman Islands |
|
0.30% |
Belgium |
|
0.17% |
Spain |
|
0.08% |
Branches
Pharma/Biotechnology |
|
96.10% |
Healthcare services |
|
3.44% |
Cash |
|
0.45% |
Others |
|
0.01% |